Cargando…
Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
AIMS: Cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA) are used for prognostication and monitoring in patients with carcinomas, but their utility is unclear in sarcomas. The objectives of this pilot study were to explore the prognostic significance of cfDNA and investigate whether tumour-spe...
Autores principales: | Tsoi, Kim M., Gokgoz, Nalan, Darville-O'Quinn, Paige, Prochazka, Patrick, Malekoltojari, Ainaz, Griffin, Anthony M., Ferguson, Peter C., Wunder, Jay S., Andrulis, Irene L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479566/ https://www.ncbi.nlm.nih.gov/pubmed/34558310 http://dx.doi.org/10.1302/2046-3758.109.BJR-2021-0014.R1 |
Ejemplares similares
-
Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma
por: Ko, Alice, et al.
Publicado: (2022) -
Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation
por: Wunder, Jay S., et al.
Publicado: (2020) -
Aberrant Hedgehog Signaling and Clinical Outcome in Osteosarcoma
por: Lo, Winnie W., et al.
Publicado: (2014) -
Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
por: Goudarzi, Atta, et al.
Publicado: (2013) -
p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas
por: Mousses, S, et al.
Publicado: (2001)